{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:22:40Z","timestamp":1761578560582},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1488,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1365-2265.2011.04045.x","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T15:56:33Z","timestamp":1300290993000},"page":"289-293","source":"Crossref","is-referenced-by-count":4,"title":["What is the role of alternative biomarkers for coronary heart disease?"],"prefix":"10.1111","volume":"75","author":[{"given":"Abhimanyu","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","article-title":"A general cardiovascular risk profile: the Framingham Study","volume":"38","author":"Kannel","year":"1976","journal-title":"American Journal of Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/acprof:oso\/9780198525738.003.0004","volume-title":"Coronary Heart Disease Epidemiology: From Aetiology to Public Health","author":"Stamler","year":"2005"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). [see comments]","volume":"285","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.108.816694","article-title":"Predicting the 30-year risk of cardiovascular disease: the framingham heart study","volume":"119","author":"Pencina","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11886-009-0065-1","article-title":"Emerging inflammatory markers for assessing coronary heart disease risk","volume":"11","author":"Corson","year":"2009","journal-title":"Current Cardiology Reports"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2010.09.002","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-151-7-200910060-00010","article-title":"Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force","volume":"151","author":"Helfand","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-151-7-200910060-00008","article-title":"Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement","volume":"151","author":"U.S. Preventive Services Task Force","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-genom-082509-141637","article-title":"Genetics of coronary artery disease","volume":"11","author":"Musunuru","year":"2010","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/bmj.319.7224.1562","article-title":"When can a risk factor be used as a worthwhile screening test?","volume":"319","author":"Wald","year":"1999","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ije\/dyn353","article-title":"Commentary: C-reactive protein and risk prediction - moving beyond associations to assessing predictive utility and clinical usefulness","volume":"38","author":"Vasan","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Statistics in Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/HCO.0b013e32832ac21a","article-title":"Lipoprotein a: where are we now?","volume":"24","author":"Tziomalos","year":"2009","journal-title":"Current Opinion in Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/HCO.0b013e32832f0a5b","article-title":"Lipoprotein(a): a causal independent risk factor for coronary heart disease?","volume":"24","author":"Gudnason","year":"2009","journal-title":"Current Opinion in Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60488-6","article-title":"Lp-PLA(2) and risk of atherosclerotic vascular disease","volume":"375","author":"Rosenson","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force","volume":"151","author":"Buckley","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2010.02.019","article-title":"Multiple biomarkers for predicting cardiovascular events: lessons learned","volume":"55","author":"Wang","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1371\/journal.pone.0003011","article-title":"The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants","volume":"3","author":"Lawlor","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jacc.2009.12.047","article-title":"Multimarker prediction of coronary heart disease risk: the Women\u2019s Health Initiative","volume":"55","author":"Kim","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng.782","article-title":"A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease","volume":"43","author":"Peden","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1111\/j.1365-2265.2011.04045.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.783","article-title":"Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population","volume":"43","author":"Wang","year":"2011","journal-title":"Nature Genetics"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04045.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04045.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T08:17:32Z","timestamp":1613204252000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1365-2265.2011.04045.x"}},"subtitle":["Role of alternative biomarkers for CHD"],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04045.x","relation":{},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}